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Introduction 
 
Protoporphyrin IX (PpIX) is excessively accumulated in tumor cells compared with 
normal cells.  This phenomenon is related to the generally increased activity of most 
enzymes and decreased activity of ferrochelatase. The accumulation of PpIX in the 
mitochondria causes direct cell death after light irradiation. In this study, we 
investigated the mechanism of ALA-induced PpIX accumulation and 
ALA-PDT-induced cell death in PC-3 cells.   
 
Materials and Methods 
 
1. PpIX accumulation and PDT 
PC-3 cell line derived from a poorly differentiated human adenocarcinoma. PC-3 
cells were maintained in Dulbecco’s modified Eagle’s medium (DMEM) supplemented 
with 10% FBS. To induce PpIX accumulation, PC-3 cells (1 X 105 cells/ml) were 
cultured overnight. For ALA-PDT, the cells were exposed for 10 min. As a light source, 
a Na-Li lamp (TheraBeam, VR630, USHIO Inc.) was used. The wavelength of light was 
600-700 nm, preferentially 630-670 nm. A power density of 20-65 mW/cm2 could be 
attained and 29 mW/cm2 was used in most experiments.   
 
2. Flow cytometric analysis 
The accumulated PpIX content was measured by flow cytometry with a FACScan 
apparatus (Becton Dickinson, San Jose, CA). Fluorescence intensity of the cells was 
recorded and represented the relative intracellular PpIX content. Fluorescence 
isothiocyanate (FITC)-annexin V/PI double staining was used in the flow cytometric 
detection of apoptosis and necrosis. Mitochondria were selectively stained with JC-1 or 
TMRE for detection of mitochondrial membrane potential.  
 
3. Assay for caspase-like activity 
Caspase-3 activity was determined in 20 mM HEPES buffer (pH7.5) containing 0.1 
mM NaCl and 5 mM DTT at 37°C using 1 µM Ac-DEVD-AFC (acetyl-L-aspartyl-L 
-glutamyl-L-valyl-L-aspartic acid alpha-(7-amido-4-trifluoromethyl-coumarin)) as a 
substrate. The fluorescence of released AFC was measured using a fluorescence plate 
reader with excitation and emission wavelengths of 355 and 460 nm, respectively. 
 
4. ALA-mediated PDD and PDT in vivo 
Animal experiments were conducted in accordance with the institutional guidelines 
and regulations and reviewed by the animal experiment and welfare committee of Kochi 
medical school. Each BALB/c nu/nu mice was injected in the dorsal region 
subcutaneously with 2x106 PC-3 cells suspended in 100 µl of DMEM.   
In pathological analysis, we analyzed cell death by immunohistochemistry for 
single-stranded DNA (ssDNA) to detect the degenerated tissue and measured the range 
of degenerated lesion in the tumor.  The apoptotic cells were counted in areas with 
high frequency under 10 high-power fields. More than 1000 tumor cells were counted to 
calculate the apoptosis index (AI) from these areas, and the AI values are expressed as 
percentage of ssDNA-positive cells.   
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Results 
 
1. Increase in accumulated intracellular PpIX level by inhibition of ferrochelatase 
in ALA-treated PC-3 cells 
Both an iron chelator, deferoxamine, and a NO generator, NOC-18, significantly 
increased the level of PpIX even in the presence of a low concentration of ALA, such as 
0.1 or 0.25 mM.   
 
2. Effect of PDT on the cell death of ALA-treated PC-3 cells 
The results of analysis of PDT-induced PS externalization and PI stainability 
suggested that PDT induced cell death by both necrosis and apoptosis. After 
photodynamic treatment, the cells were damaged more severely by ALA-PDT plus 
treatment with deferoxamine or NOC-18 than ALA-PDT alone. Deferoxamine and 
NOC-18 significantly increased the PDT-induced cell death. The levels of mitochondrial 
membrane potential decreased in parallel with increased cell death in PC-3 cells after 
ALA-PDT in a time-dependent manner. Furthermore, the depolarization was stimulated 
by the inhibition of ferrochelatase activity even after incubation with 0.1 mM ALA.   
 
3. ALA-PDT increases the activity of caspase-like enzyme 
The caspase-3 activation was time-dependent and was increased by the treatment 
with deferoxamine and NOC-18. However, activation of the enzyme by ALA-PDT was 
not significantly increased. The inhibition of caspase-3 activation by z-VAD-fmk did 
not attenuate the ALA-PDT-induced cell death and membrane depolarization of PC-3 
cells.  
 
4. Effect of ALA-mediated PDT on prostate cancer cells in vivo 
In the pathological analysis, the degeneration was observed within a broader range in 
the therapeutic group than in the control group. However, the promoting effect of 
ALA-PDT by deferoxamine was not significant. There was a significant difference in AI 
between the control group and the ALA/PDT group or the ALA/DFX/PDT group.  
However, there was no significant difference in AI between the ALA/PDT group and the 
ALA/DFX/PDT group.   
 
Discussion 
 
ALA is a naturally occurring metabolite that is a precursor of porphyrin in heme 
biosynthesis. Exogenous ALA leads to the accumulation of the potent photosensitizer 
PpIX in mitochondria. The mechanism of ALA-PDT-induced cell death by inhibition of 
ferrochelatase revealed that ALA-PDT-induced cell death led to apoptosis and necrosis.  
Caspase-3-like activity was not significant and a pan-caspase inhibitor, z-VAD-fmk, did 
not attenuate cell death and membrane depolarization. These results suggest that 
ALA-PDT induced not only necrosis (partially dependent on membrane depolarization) 
but also apoptosis that might have occurred via a caspase-independent mitochondrial 
pathway. We could demonstrate a weak but significant cytoreductive effect of 
ALA-PDT and a small promoting effect of ALA-PDT by deferoxamine in PC-3 cells in 
vivo. From the results of our present study, we conclude that ALA-mediated 
accumulation and distribution of PpIX are strongly regulated by heme synthesis system 
and hence we can achieve clinically favorable results by using ferrochelatase inhibitors.  
